Researchers at UK's College of Medicine have found that a class of antibiotics could be promising treatment for a form of dementia. Results of their proof of concept study were recently published in the journal Human Molecular Genetics.
New research shows that the microorganisms in our gut could help protect brain cells from damage caused by inflammation after a stroke. The study reveals that supplementing the body’s short chain fatty acids could improve stroke recovery.
Lance Cpl. Benjamin Shaw is currently in his fourth year of the UK College of Medicine’s PhD program in physiology, studying the effect genetic differences have on immune cell function related to Alzheimer’s disease risk.
The UK College of Medicine will host the 2019 Obstetrical Neurology Conference on Friday, Sept. 6, 2019 for faculty, providers and trainees in neurology, obstetrics, anesthesia and women's health interested in neurological issues in the pregnant patient.
Thanks to volunteers, SBCoA has played a role in many landmark discoveries, including debunking the theories that aluminum or mercury cause Alzheimer's, identifying so-called "AD mimics", and proving that there are changes in the brain decades before there are outward symptoms of AD.
A team of scientists have designed and tested a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy.
Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.
In this episode of "Behind the Blue," Sanders-Brown director Linda Van Eldik talks about the center's involvement in some of the most important discoveries in the history of Alzheimer's research and what they are doing now to advance the science.
